NCT02157311View on ClinicalTrials.gov

4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
HIV-1 Infection
Interventions
DRUG

Four consecutive days on treatment and 3 days off

All patients will take a combination of three of these treatment with a weekly strategy of 4 consecutive days on treatment followed by 3 days off treatment

Trial Locations (17)

14033

CHU Côte de Nacre, Caen

21079

Hôpital Le Bocage, Dijon

31059

Hôpital Purpan, Toulouse

34295

Hôpital Gui de Chauliac, Montpellier

37044

Hôpital Bretonneau, Tours

75012

Hôpital Saint-Antoine, Paris

75013

Hôpital Pitié-Salpêtrière, Paris

75015

Hôpital Européen Georges Pompidou, Paris

Hôpital Necker, Paris

75018

Hôpital Bichat, Paris

75020

Hôpital Tenon, Paris

91100

Centre Hospitalier Sud Francilien, Corbeil-Essonnes

92151

Hôpital Foch, Suresnes

92380

Hôpital Raymond Poincaré, Garches

93000

Hôpital Avicenne, Bobigny

94275

Hôpital Bicêtre, Le Kremlin-Bicêtre

97261

Hôpital Meynard, Fort-de-france

All Listed Sponsors
lead

ANRS, Emerging Infectious Diseases

OTHER_GOV

NCT02157311 - 4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV Patients | Biotech Hunter | Biotech Hunter